JeremyKHonMD
Oncology • Huntsville, ALHematologic Oncology
Director, stem cell transplant program Huntsville hospital
Dr. Hon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3601 Cci Dr NW
Huntsville, AL 35805Phone+1 256-705-4224Fax+1 256-705-4135
Summary
- Dr. Jeremy Hon is an oncologist in Huntsville, AL and was affiliated with multiple hospitals in the area, including Crestwood Medical Center and Huntsville Hospital.He received his medical degree from University of Alabama School of Medicine and has been in practice 41 years. He is experienced in hematology medical oncology and autologous stem cell transplant. He recently retired from his practice at clearview cancer institute in huntsville, Alabama. He is currently residing overseas in an area relatively safe from COVID-19
Education & Training
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineFellowship, Hematology and Medical Oncology, 1983 - 1985
University of Texas Health Science Center at HoustonResidency, Internal Medicine, 1980 - 1983
University of Alabama School of MedicineClass of 1980
Certifications & Licensure
AL State Medical License 1985 - 2021
TN State Medical License 1990 - 1994
TX State Medical License 1981 - 1993
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2012-2013
Publications & Presentations
PubMed
- 558 citationsWeekly nab-Paclitaxel in Combination With Carboplatin Versus Solvent-Based Paclitaxel Plus Carboplatin as First-Line Therapy in Patients With Advanced Non–Small-Cell L...Mark A. Socinski, Igor Bondarenko, Nina Karaseva, Anatoly M. Makhson, Igor Vynnychenko
Journal of Clinical Oncology. 2012-06-10 - 35 citationsGemcitabine and vinorelbine in the second-line treatment of nonsmall cell lung carcinoma patients: a minnie pearl cancer research network phase II trial.John D. Hainsworth, Howard A. Burris, Sharlene Litchy, Joan B. Erland, Jeremy K. Hon
Cancer. 2000-03-15 - 53 citationsSafety and efficacy analysis by histology of weekly nab-paclitaxel in combination with carboplatin as first-line therapy in patients with advanced non-small-cell lung ...Mark A. Socinski, Isamu Okamoto, Jeremy K. Hon, Vera Hirsh, Shaker R. Dakhil
Annals of Oncology. 2013-09-01
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
